You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Rationale and design of the ranolazine PH–RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension

Citation Tools

Article menu

Download PDFPDF

Pulmonary vascular disease
Protocol
Rationale and design of the ranolazine PH–RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Han Y, Forfia PR, Vaidya A, et al
Rationale and design of the ranolazine PH–RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension
Open Heart 2018;5:e000736. doi: 10.1136/openhrt-2017-000736